Kothari Fermentation & Biochem Ltd (KFBL) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Kothari Fermentation & Biochem Ltd on NSE and BSE, with an AI summary of each filing.
Please refer to the attached annexure w.r.t. Commercial Arrangements between Kothari Fermentation and Biochem Limited and Oriental Yeast India Private Limited.
Others (Uncategorized) · 07 Oct 2026, 4:59 pm
Kothari Fermentation Partners With Oriental Yeast India for Manufacturing and Distribution Kothari Fermentation and Biochem Ltd (KFBL) entered into domestic commercial agreements with Oriental Yeast India Pvt Ltd (OYI) on 6th Oct'26 to optimize yeast manufacturing and distribution. Under the pact, KFBL will handle manufacturing services for yeast and related products, while OYI—a subsidiary of Japan's Oriental Yeast Co. Ltd with a paid-up capital of Rs 1,078.05 Cr—will provide technical support and distribution services. The deal involves no upfront consideration, imposes no management control impact or liabilities on KFBL, and aims to enhance product quality and operational efficiency.
Please refer to the attached annexure.
Annual General Meeting · 01 Oct 2026, 1:17 am
Kothari Fermentation AGM Approves All Resolutions Including Key Executive Remuneration Revisions Kothari Fermentation and Biochem Ltd. shareholders approved all four resolutions at the 36th AGM held on 30th Sep'26. Total valid votes cast reached 10,682,580 (71.22% turnout). The adoption of FY26 audited financial statements and the reappointment of retiring director Pramod Kumar Kothari passed with 99.98% assent each. Special resolutions approving remuneration revisions for Chairman & Managing Director Pramod Kumar Kothari and Whole-Time Director Kavita Devi Kothari both passed with 98.56% majority support, despite 43.67% dissent from voting non-institutional public shareholders.
Please refer to the attached annexure.
Annual General Meeting · 01 Oct 2026, 1:14 am
Kothari Fermentation AGM Approves All Resolutions With Requisite Majority Kothari Fermentation and Biochem Ltd. announced the voting results of its 36th AGM held on 30th Sep'26. Shareholders approved all four proposed resolutions with requisite majorities. Key outcomes include the adoption of audited financial statements for the fiscal year ended 31st Mar'26 (99.98% votes in favor), the reappointment of Pramod Kumar Kothari as Director retiring by rotation (99.98% favor), and special resolutions revising the remuneration of Pramod Kumar Kothari (Chairman & MD) and Kavita Devi Kothari (Whole-Time Director), both receiving 98.56% votes in favor.
Please refer to the attached annexure w.r.t. the proceedings/ outcome of the 36TH Annual General Meeting of the Company held on 30/09/2026.
Annual General Meeting · 30 Sept 2026, 10:55 pm
Please refer to the attached annexure w.r.t. the resignation of the Internal Auditor
Change in Management · 25 Sept 2026, 11:38 pm
Kothari Fermentation Announces Resignation of Internal Auditor Arun K. Garg & Associates M/s. Arun K. Garg & Associates, Chartered Accountants, has resigned as the Internal Auditor of Kothari Fermentation and Biochem Ltd. for FY27, effective 25th Sep'26. The auditor cited pre-occupation with other professional assignments and a lack of resources as the reasons for stepping down, per their letter dated 22nd Sep'26. The company stated that it is currently in the process of identifying and appointing a replacement Internal Auditor to fill the casual vacancy.
Please refer to the attached annexure.
Others (Uncategorized) · 08 Sept 2026, 6:32 pm
Kothari Fermentation Dispatches KYC Reminder Letters to Physical Shareholders Kothari Fermentation and Biochem Ltd. has completed dispatching reminder notices to shareholders holding physical securities to mandatorily submit PAN, KYC, bank details, and nominations in compliance with SEBI master circular directives. Shareholders must submit the prescribed forms (ISR-1, ISR-2, SH-13/ISR-3) to the Registrar and Transfer Agent, Abhipra Capital Ltd. Failure to update KYC details will restrict RTA service requests and halt non-electronic corporate disbursements such as dividends. The company further urged physical shareholders to dematerialize their holdings for seamless future transfers.
Please refer to the attached annexure.
Annual General Meeting · 08 Sept 2026, 6:22 pm
Kothari Fermentation Dispatches FY26 AGM Notice and Annual Report Weblinks Kothari Fermentation and Biochem Ltd. has dispatched physical intimations containing website access links for its 36th AGM Notice and FY25-26 Annual Report to shareholders without registered email addresses as of 28th Aug'26, in compliance with SEBI LODR Regulation 36(1)(b). The company’s 36th AGM is scheduled for 30th Sep'26 at 11:30 AM IST via Video Conferencing/Other Audio-Visual Means. Shareholders have also been advised to register their email credentials with the RTA, Abhipra Capital Ltd., and dematerialize physical shareholdings.
Please refer to the attached annexure w.r.t. the AGM Notice and Annual Report.
Annual General Meeting · 07 Sept 2026, 8:50 pm
Pursuant to Regulation 30 & 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and other applicable provisions, please find enclosed the Notice convening ....
Others (Uncategorized) · 07 Sept 2026, 8:44 pm
Please refer to the attached annexure w.r.t. the Notice of the 36th Annual General Meeting along with the Annual Report.
Annual General Meeting · 07 Sept 2026, 8:31 pm
Please refer to the attached annexure.
Financial Result · 13 Aug 2026, 11:33 pm
Kothari Fermentation Posts Q1'27 Profit, Reversing Prior Year Loss Kothari Fermentation reported a net profit of ₹6.45 lakh for the quarter ended 30 Jun'26, reversing a loss of ₹112.46 lakh in the same quarter last year. Revenue from operations grew 28% YoY to ₹3,041.20 lakh. However, QoQ, revenue declined 6.3% and net profit fell 95% from ₹127.26 lakh. The board also approved the re-appointment of director Pramod Kumar Kothari, subject to shareholder approval at the AGM scheduled for 30 Sep'26. Basic EPS stood at ₹0.04 versus ₹(0.75) YoY.
Please refer to the attached annexure w.r.t. Unaudited Financial Results for the quarter ended June 30, 2026, along with the Limited Review Report.
Outcome · 13 Aug 2026, 11:15 pm
Kothari Fermentation & Biochem Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR Lakh) ■ Revenue: 3,041 (+28.0% YoY | -6.3% QoQ) ■ EBITDA: 265 (+60.0% YoY | -9.0% QoQ) ■ EBITDA Margin (%): 8.7 (+174 bps YoY | -25 bps QoQ) ■ PAT: 6.5 (Loss to Profit YoY | -94.9% QoQ) ■ EPS (INR): 0.04 (Loss to Profit YoY | -95.3% QoQ)
Kothari Fermentation & Biochem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve 1. The Unaudited ....
Intimation · 13 Aug 2026, 5:30 am
Please refer to the attached annexure.
Others (Uncategorized) · 07 Jul 2026, 9:01 pm
Kothari Fermentation Receives Penalty Notice from Electricity Distributor Kothari Fermentation and Biochem received a penalty notice for ₹52,17,724 on 7 Jul'26 from Paschimanchal Vidyut Vitran Nigam Limited. The penalty pertains to an alleged delay in renewing Bank Guarantees for an Additional Security Deposit. The company has disputed the charge, stating the underlying requirement is fulfilled and the delay was caused by the electricity distributor. Kothari is pursuing legal remedies and states there is no operational impact. The financial impact is limited to the penalty amount, contingent on legal outcomes.
Please refer to the attached annexure with respect to the withdrawal of the credit rating
Others (Uncategorized) · 27 Jun 2026, 7:33 pm
Kothari Fermentation: CRISIL Withdraws Credit Rating on Repaid Bank Facilities CRISIL Ratings has withdrawn its ratings on Kothari Fermentation and Biochem's (KFBL) Rs. 44 crore bank loan facilities on 26-Jun-'26. This action follows the company's request after it fully repaid the facilities availed from Kotak Mahindra Bank and provided a No Objection Certificate. CRISIL noted the withdrawal was also due to KFBL's failure to provide adequate information for rating assessment, which restricts a forward-looking view on its credit quality and is consistent with the agency's policy on 'Assessing Information Adequacy Risk'.
Details are as per the enclosed annexure.
Change in Management · 30 May 2026, 2:50 am
Kothari Fermentation FY26 Results & Board Meeting Outcomes Kothari Fermentation & Biochem reported a net profit of Rs. 127.26 lakhs for Q4FY26, up from Rs. 105.13 lakhs YoY. For FY26, the company posted a net loss of Rs. 298.93 lakhs, a significant decline from a profit of Rs. 80.99 lakhs in FY25. Revenue from operations for FY26 stood at Rs. 11,213.19 lakhs vs. Rs. 11,423.10 lakhs YoY. The Board approved the audited results and appointed M/s Arun K. Garg & Associates as internal auditors for FY27. Auditors issued an unmodified opinion.
Financial Results for the Quarter and Financial Year Ended March 31, 2026
Financial Result · 30 May 2026, 12:31 am
Kothari Fermentation FY26 Results & Governance Updates Kothari Fermentation reported a net profit of ₹127.26 lakhs for Q4 FY26, a significant turnaround from a loss of ₹37.84 lakhs in Q3 FY26, but down from ₹105.13 lakhs in Q4 FY25. Revenue from operations for the quarter stood at ₹3,246.80 lakhs. For the full year FY26, the company recorded a net loss of ₹298.93 lakhs on revenues of ₹11,213.19 lakhs. The Board approved the appointment of M/s Arun K. Garg & Associates as internal auditors for FY27. The statutory auditor issued an unmodified opinion.
Outcome for Audited (Standalone) Financial Results for the Quarter and Financial Year ended March 31, 2026, Appointment of Internal Auditor
Outcome · 29 May 2026, 11:58 pm
Kothari Fermentation & Biochem Ltd - Financial Result for the Quarter ended 31st Mar'26 (Standalone, INR Lakh) ■ Revenue: 3,247 (+0.9% YoY | +1.6% QoQ) ■ EBITDA: 291 (-34.1% YoY | +22.4% QoQ) ■ EBITDA Margin (%): 9.0 (-477 bps YoY | +152 bps QoQ) ■ PAT: 127 (+21.1% YoY | Loss to Profit QoQ) ■ EPS (INR): 0.85 (+21.4% YoY | Loss to Profit QoQ)
Kothari Fermentation & Biochem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve the Audited ....
Intimation · 29 May 2026, 5:30 am
Kothari Fermentation Sets Board Meeting for Q4 & FY26 Results on May 29, 2026 Kothari Fermentation & Biochem Ltd. scheduled a Board of Directors meeting on Fri, 29 May '26, to consider and approve the Audited Financial Results for the quarter and financial year ended 31 Mar '26. The company also confirmed its trading window, which closed on 24 Mar '26, will remain shut until 48 hours after the results are declared. This closure applies to all designated persons and their immediate relatives in compliance with SEBI insider trading regulations.
Please refer to the attached annexure.
Change in Management · 08 Apr 2026, 6:11 pm
Kothari Fermentation Approves Key Director Reappointments and Remuneration Revisions On 08 Apr'26, Kothari Fermentation's board approved the re-appointment and remuneration revision for key directors, subject to shareholder approval. Chairman & MD Pramod Kumar Kothari was re-appointed for three years effective 01 Apr'26 with a revised remuneration of Rs. 6,00,000 per month. Whole Time Director Kavita Devi Kothari was also re-appointed for three years from 01 Apr'26 with a revised remuneration of Rs. 5,75,000 per month. Both appointments are for a three-year term ending 31 Mar'29.
Please refer to the attached annexure
Change in Management · 27 Mar 2026, 10:39 pm
Kothari Fermentation Appoints New Executive Director Kothari Fermentation and Biochem has appointed Ms. Janhavi Kothari as Executive Director to manage its Purchase Department, effective 1st Apr'26. She holds a B.Tech in Computer Science and Engineering and has prior experience as a Procurement Analyst. Ms. Kothari is the daughter-in-law of the Chairman & MD, Mr. Pramod Kumar Kothari, and the wife of Whole-Time Director, Mr. Siddhant Kothari, highlighting a key related-party appointment within senior management. The decision was approved by the Board on 27th Mar'26.
Please refer to the attached annexure
Change in Management · 27 Mar 2026, 10:39 pm
Kothari Fermentation Appoints Janhavi Kothari as Executive Director Kothari Fermentation & Biochem's Board of Directors has approved the appointment of Ms. Janhavi Kothari as Executive Director, effective 1st Apr'26. She will manage the company's Purchase Department. Ms. Kothari holds a B.Tech in Computer Science and has prior experience as a Procurement Analyst. She is the daughter-in-law of Chairman and MD Pramod Kumar Kothari and the wife of Whole-Time Director Siddhant Kothari, highlighting a key related-party transaction involving senior management personnel.
Please refer to the attached annexure.
Financial Result · 13 Feb 2026, 11:31 pm
Kothari Fermentation Reports Q3'26 Loss Amid Higher Expenses Kothari Fermentation & Biochem reported a net loss of Rs. 37.84 lakhs for the quarter ended 31st Dec'25, compared to a profit of Rs. 41.09 lakhs YoY. The loss was driven by a widened loss before tax of Rs. 27.33 lakhs versus a Rs. 72.09 lakh profit YoY. Revenue from operations grew 4.6% YoY to Rs. 3,194.97 lakhs. However, total expenses rose 8.1% YoY to Rs. 3,223.09 lakhs, primarily due to increased material and power costs, eroding profitability. Basic EPS stood at Rs. (0.25).
Please refer to the attached annexure.
Outcome · 13 Feb 2026, 11:25 pm
KOTHARI FERMENTATION AND BIOCHEM LIMITED - Financial Result for the Quarter ended 31st Dec'25 (Standalone, INR Lakhs) ■ Revenue: 3195 (+4.6% YoY | +33.3% QoQ) ■ EBITDA: 238 (-25.2% YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 7.4 (-297 bps YoY | Loss to Profit QoQ) ■ PAT: -37.8 (Profit to Loss YoY | +87.7% QoQ) ■ EPS (INR): -0.25 (Profit to Loss YoY | +87.8% QoQ)
Kothari Fermentation & Biochem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve Unaudited Financial ....
Intimation · 13 Feb 2026, 5:30 am
Kothari Fermentation Board Meeting Set for Feb 13, 2026, to Approve Q3FY26 Results Kothari Fermentation and Biochem Ltd. (BSE: 507474) has scheduled a Board of Directors meeting on 13th Feb'26. The primary agenda is to consider and approve the unaudited financial results for the quarter and nine months ended 31st Dec'25. In line with insider trading regulations, the trading window for designated persons remains closed until 48 hours after the results are declared. This closure was initially communicated on 26th Dec'25. The meeting will also address other business items as necessary.